| First Author | Kim DK | Year | 2019 |
| Journal | Biochim Biophys Acta Mol Cell Biol Lipids | Volume | 1864 |
| Issue | 12 | Pages | 158521 |
| PubMed ID | 31479733 | Mgi Jnum | J:280910 |
| Mgi Id | MGI:6370278 | Doi | 10.1016/j.bbalip.2019.158521 |
| Citation | Kim DK, et al. (2019) Estrogen-related receptor gamma controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver. Biochim Biophys Acta Mol Cell Biol Lipids 1864(12):158521 |
| abstractText | Although SREBP-1c regulates key enzymes required for hepatic de novo lipogenesis, the mechanisms underlying transcriptional regulation of SREBP-1c in pathogenesis of alcoholic fatty liver is still incompletely understood. In this study, we investigated the role of ERRgamma in alcohol-mediated hepatic lipogenesis and examined the possibility to ameliorate alcoholic fatty liver through its inverse agonist. Hepatic ERRgamma and SREBP-1c expression was increased by alcohol-mediated activation of CB1 receptor signaling. Deletion and mutation analyses of the Srebp-1c gene promoter showed that ERRgamma directly regulates Srebp-1c gene transcription via binding to an ERR-response element. Overexpression of ERRgamma significantly induced SREBP-1c expression and fat accumulation in liver of mice, which were blocked in Srebp-1c-knockout hepatocytes. Conversely, liver-specific ablation of ERRgamma gene expression attenuated alcohol-mediated induction of SREBP-1c expression. Finally, an ERRgamma inverse agonist, GSK5182, significantly ameliorates fatty liver disease in chronically alcohol-fed mice through inhibition of SREBP-1c-mediated fat accumulation. ERRgamma mediates alcohol-induced hepatic lipogenesis by upregulating SREBP-1c expression, which can be blunted by the inverse agonist for ERRgamma, which may be an attractive therapeutic strategy for the treatment of alcoholic fatty liver disease in human. |
